Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase - 04/12/23
Abstract |
The high expression of BLM (Bloom syndrome) DNA helicase in tumors involves its strong association with cell expansion. Bisbenzylisoquinoline alkaloids own an antitumor property and have developed as candidates for anticancer drugs. This paper aimed to study the antitumor effect of fangchinoline derivative HY-2 by targeting BLM642–1290 DNA helicase, and then explore its inhibitory mechanism on proliferation of MDA-MB-435 breast cancer cells. We confirmed that the mRNA and protein levels of BLM DNA helicase in breast cancer were higher than those in normal tissues. HY-2 could inhibit the DNA binding, ATPase and DNA unwinding of BLM642–1290 DNA helicase with enzymatic assay. HY-2 could also inhibit the DNA unwinding of DNA helicase in cells. In addition, HY-2 showed an inhibiting the MDA-MB-435, MDA-MB-231, MDA-MB-436 breast cancer cells expansion. The mRNA and protein levels of BLM DNA helicase in MDA-MB-435 cells increased after HY-2 treatment, which might contribute to HY-2 inhibiting the DNA binding, ATPase and DNA unwinding of BLM DNA helicase. The mechanism of HY-2 inhibition on BLM DNA helicase was further confirmed with the effect of HY-2 on the ultraviolet spectrogram of BLM642–1290 DNA helicase and Molecular dynamics simulation of the interacting between HY-2 and BLM640–1291 DNA helicase. Our study provided some valuable clues for the exploration of HY-2 in the living body and developing it as an anticancer drug.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | We identified a new small-molecule BLM DNA helicase inhibitor, fangchinoline derivative HY-2. |
• | HY-2 inhibits breast cancer cells expansion, which associated with it suppressing BLM DNA helicase. |
• | HY-2 is expected to be a therapeutic candidate for breast cancer. |
Abbreviations : BLM, BS, DTT, ELISA, GFP, HJNO, HRDC, HY-2, IHC, MDA-MB-231, MDA-MB-435, MMC, MTT, PBS, RT-PCR, RPA
Keywords : Breast cancer, BLM DNA helicase, Bisbenzylisoquinoline alkaloid, Fluorescence polarization, Molecular dynamics simulation
Plan
Vol 169
Article 115908- décembre 2023 Retour au numéro
Article précédent
- Veronica persica ameliorates acetaminophen-induced murine hepatotoxicity via attenuating oxidative stress and inflammation
- Wei-shun Tian, Jing Zhao, Myung-Kon Kim, Hyun-Jin Tae, In-Shik Kim, Dongchoon Ahn, Hong Pil Hwang, Ming-xian Mao, Byung-Yong Park
- Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial
- Lucrezia Spadera, Marina Lugarà, Maria Spadera, Mariano Conticelli, Gabriella Oliva, Vincenzo Bassi, Valentina Apuzzi, Francesco Calderaro, Olimpia Fattoruso, Pietro Guzzi, Maurizio D’Amora, Oriana Catapano, Roberta Marra, Maria Galdo, Michele Zappalà, Toshio Inui, Martin Mette, Giuseppe Vitiello, Maria Corvino, Giuseppe Tortoriello
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?